Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of neuropathic pain, less than half of surveyed ...
UK patients suffering from severe chronic pain have been given a new treatment option in the form of Gruenenthal's novel painkiller Palexia SR, which has just been launched throughout the country. UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results